connect with us
For further information please fill the details below:
Skip to main content

ANNOUNCEMENT

nmims-npat-2019logosLC-MS/MS facility at the SPPSPTMApplications invited for JRF positionAttend Info-session on B.Pharm. + MBA
sarika-wairkar

Dr. Sarika Wairkar

Assistant Professor

M. Pharm., Ph.D

Specialization

Quality Assurance

Email Id

sarika.wairkar@nmims.edu

Phone No.

022-42332000

Experience

14 Years 02months

(Industry: Six years and 4 months, Academic: Seven years and 10 months)

She has six and half years of rich experience of R & D in the field of formulation development and quality assurance. She has worked in ‘Formulation development’ of solid dosage form including immediate release tablets/ capsules, extended release tablets/capsules, controlled release tablets, effervescent tablets for regulatory markets and successfully completed technology transfer of the developed products for commercial production. She has expertise in trouble shooting at production plant, development report preparation and technology transfer for regulatory market. Recently she has published series of good impact factor research and review papers.

Interest areas: 

  • Nasal drug delivery
  • Nanotechnology
  • Particle Engineering of drugs

Research

  • Publications - 16 (International- 16)
  • Patents- 2 (Provisional)
  • Presentations - 10 (International - 5, National - 5 )
  • Government funded projects – 01
    • Completed
    • Received grant of 20,00,000 for project titled “Novel intranasal delivery of Antiparkinson agents” from Council of Scientific & Industrial Research (CSIR)- Extramural Research Division for 2013-2017.
  • Industry projects - 1
    • Completed
    • Industry sponsored project titled “Formulation and development of Generic products” (For US market), of 4 Lakhs, by Intelliscend pvt. Ltd for 6 months received in January 2016.
  • Seed grant of 80,000/ by NMIMS university- (Completed)

Conferences/Workshops/Seminars attended

25

Academic activities

She has guided 17 M.Pharm. students for their major research projects and 16 M.Pharm. students for their minor research projects.

Awards

  • Recipient of ICMR travel grant 1.5 lacs for presenting research paper in “The 44th Annual Meeting & Exposition of the Controlled Release Society” at Boston, USA, July, 2017
  • Recipient of Best faculty (Teaching) for SPPSPTM, NMIMS, Mumbai for year 2017-2018
  • Secured Second Rank at M.Pharm, in the merit list of Bharati Vidyapeeth Deemed University, Pune.
  • Gold medalist, B. Pharm examination, Shivaji University, Kolhapur.
  • Recipient of ‘Best outgoing student award’ Bharati Vidyapeeth College of Pharmacy Kolhapur, year 2002.
  • Recipient of prestigious ‘Prof. M. L. Khorana Award and Merit Certificate” for standing first in Shivaji University, Kolhapur (B. Pharm).
  • The Indian Pharmaceutical Association (Maharashtra state branch) recogniton certificate and medal for standing first in the B.Pharm Examination of Shivaji University.

Professional Memberships

  • Life Member, Association for Pharmaceutical Teachers of India (MA-LM-2085)
  • Life Member, Indian Pharmaceutical Association (MAH/BOM/LM-1426)
  • Life Member of Society of Pharmaceutical Education and Research, Dehradun.

Recent Publications

  1. Joshi R, Kulkarni YA, Wairkar S*. Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update. Life sciences. 2018, 215: 43-56. (Impact factor-3.2)
  2. Sridhar V, Gaud R, Bajaj A, Wairkar S*. Pharmacokinetics and pharmacodynamics of intranasally administered selegiline nanoparticles with improved brain delivery in Parkinson's disease. Nanomedicine: Nanotechnology, Biology and Medicine. 2018 Nov 1;14(8):2609-18. (Impact factor-6.5)
  3. R Rajput, S Wairkar*, R Gaud. Nutraceuticals for better management of osteoporosis: An overview. Journal of Functional Foods. 2018 Aug 31; 47: 480-90. (Impact factor-3.47)
  4. Ruhi Raj, S Wairkar*, Vinay Sridhar, Ram Gaud; Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity; International Journal of Biological Macromolecules; Volume 109, 1 April 2018, Pages 27–35. (Impact factor-3.67).
  5. Sridhar V, S Wairkar*, R Gaud, A Bajaj, P Meshram. Brain targeted delivery of Mucoadhesive Thermosensitive Nasal Gel of Selegiline Hydrochloride for treatment of Parkinson's disease. Journal of Drug Targeting. 2018 Feb 7; 26(2):150-61. (Impact factor-3.08).
Connect With Us x